About Cancer Drug Development Forum
Cancer Drug Development Forum is a non-profit association (VZW/ASBL) based in Sint-Lambrechts-Woluwe, founded in 2019. Its main activity is classified as "Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering". For the 2025 financial year, Cancer Drug Development Forum reported a profit of €9,186. A year earlier, in 2024, it still made a loss of €10,979. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €299,956, up 8.6% on 2024. It employed an average of 3 full-time equivalents. Equity stands at €809,743, a solvency ratio of 49%. 3 annual accounts are available, covering 2023 to 2025.
- Signals
-
ProfitableProfitable € 9K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 810KStrong equity provides a buffer against setbacks.
Low riskLow risk 48.6%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.94A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 11KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 11KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 19.3%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|
|
€
300K
|
€
276K
|
€
298K
|
|
|
€
11K
|
€
-11K
|
€
37K
|
|
|
€
9K
|
€
-11K
|
€
33K
|
|
|
€
810K
|
€
801K
|
€
812K
|
|
|
48.58%
|
48.32%
|
60.17%
|
|
|
€
857K
|
€
856K
|
€
537K
|
|
|
€
1.13M
|
€
983K
|
€
1.03M
|
|
|
3
|
3.60
|
2.70
|
Publications 12
All publications- Demissions, Nominations 26/08/2026
- Demissions, Nominations 23/07/2026
- Demissions, Nominations 04/12/2025
- Demissions, Nominations 03/07/2025
- Demissions, Nominations 09/04/2025
Frequently asked questions
Answers to the most common questions about Cancer Drug Development Forum, based on official government data and the filed annual accounts.
What is the VAT number of Cancer Drug Development Forum?
The VAT number of Cancer Drug Development Forum is BE0738.523.752.
How many employees work at Cancer Drug Development Forum?
In 2025, Cancer Drug Development Forum employed 3.00 full-time equivalents (FTE).
When was Cancer Drug Development Forum established?
Cancer Drug Development Forum was founded in 28-11-2019.
What is the official address of Cancer Drug Development Forum?
The official address of Cancer Drug Development Forum is Veldkapelgaarde 30 Sint-Lambrechts-Woluwe 1200 1.30.30.
What is the legal form of Cancer Drug Development Forum?
The juridical form of Cancer Drug Development Forum is Non-profit association (VZW/ASBL).
What is the annual revenue of Cancer Drug Development Forum?
The 2025 accounts of Cancer Drug Development Forum do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Cancer Drug Development Forum a reliable company?
Cancer Drug Development Forum is a registered Rechtspersoon with company number 0738.523.752 and can be verified through the official CBE database.
What is the credit limit of Cancer Drug Development Forum?
The estimated credit limit of Cancer Drug Development Forum is €50,274.
Is Cancer Drug Development Forum still active?
Cancer Drug Development Forum currently has the status "Normal situation" and is active.
More companies in Sint-Lambrechts-Woluwe
Show all- X Xocola BV · since 2019
- M Monoflux BV · since 2019
- DD Dental Dive BV · since 2019
- HP H&S Powersolutions BV · since 2019
- NT New Talent Capital BV · since 2019
- CC Construction Care Global Solutions BV · since 2019